The authors have developed an innovative, unique device and technology for analyzing biological fluids and tested it under laboratory conditions. This technology has shown promising results for further improvement and application in clinical laboratory practice for in-depth diagnostics of biological fluids for various diseases. The proposed technology is of great importance for the healthcare system in Germany and around the world. We are looking for an investor to finance the realization of this project from the seed stage to market entry. The investment required at the seed stage is 2 million euros. The period for completing stages 1-4 is 1 year. At the end of stage 4, the plan is to have a laboratory-tested industrial prototype and server software based on artificial intelligence.